Ekso Bionics Holdings, Inc. Quarterly report pursuant to Section 13 or 15(d)

Note 3 - Accumulated Other Comprehensive Income (Loss) (Tables)

3 Months Ended

Mar. 31, 2024

	*Three Months Ended March 31,*
	*2024*		*2023*
Balance at beginning of period	$	156	$	563
Net unrealized gain (loss) on foreign currency translation		291		(194	)
Balance at end of period	$	447	$	369